News
Natalie Hayden was a young adult when she was diagnosed with Crohn's disease. Her mom once again became her caregiver.
Fact checked by Nick Blackmer As a parent, one of your greatest fears is having your child be diagnosed with a life-long ...
Discover ways to balance Crohn's disease symptoms with an active social life, from communicating needs to friends to ...
When symptoms flare up, it can be challenging for people with Crohn’s disease—a chronic inflammatory bowel disease–to ...
Parkinson's is a devastating disease that affects families throughout the country. But here in the Delaware Valley, one physical therapist is taking a unique approach to treating it. It packs ...
BBC Sports presenter Adlington, 36, who shot to fame as an Olympic swimmer, made a plea to UK Government in a short clip explaining she has coeliac disease. In the video shared to Coeliac UK’s ...
The Olympic swimmer, 36, made a plea to UK Government in a short clip in which she explained she has coeliac disease. In the video shared to Coeliac UK's Instagram, she said: 'Hello everyone.
Tremfya is the only IL-23 inhibitor with IV and SC induction options for treating Crohn disease. The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease. This approval is the fourth ...
The US Food and Drug Administration (FDA) approved guselkumab (Tremfya, Johnson & Johnson) for the treatment of adults with moderate to severe active Crohn’s disease (CD). The approval marks the ...
Tremfya-treated patients achieved statistically significant clinical remission and endoscopic response compared with placebo at weeks 0, 4, and 8. HealthDay News — The US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results